NCT04126668View on ClinicalTrials.gov

A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 19, 2019

Primary Completion Date

January 16, 2020

Study Completion Date

January 16, 2020

Conditions
Advanced Malignant Solid Tumors
Interventions
DRUG

CM082 with fed or fasting

The two groups of subjects were given an equal dose of CM082 tablet (200 mg) after a single cross-over fasting or high-fat high-calorie diet in two different test cycles to examine the effect of food on the pharmacokinetics of CM082.

Trial Locations (1)

311009

The 1st Phase Clinical Research Center of the Second Affiliated Hospital of Zhejiang University Medical College, Hangzhou

Sponsors

Lead Sponsor

AnewPharma
All Listed Sponsors
lead

AnewPharma

INDUSTRY

NCT04126668 - A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers | Biotech Hunter | Biotech Hunter